Dr Steven Wise wins prestigious NHMRC award

Awards and Achievements
Dr Steven Wise has been presented the prestigious National Health and Medical Research Council (NHMRC) Marshall and Warren Award.

The Marshall and Warren Award recognises the most innovative research project that could change the way an illness or disease is diagnosed, treated or prevented, from among all the applications nominated for this award in each year’s NHMRC Project Grants.

Dr Wise leads the Applied Materials group at the Heart Research Institute, focusing on developing the next generation of translatable bioactive materials – materials that can bond to living tissues – to provide better treatment options for people with cardiovascular disease. 

“I love coming to work every day. My research is constantly geared towards making a clinical difference, so every experiment brings us closer to that goal,” Dr Wise says.

Award winners at the NHMRC 2018 Research Excellence Awards

Dr Wise is one of 23 of Australia’s most outstanding researchers honoured at this year’s NHMRC annual Research Excellence Awards held in Canberra, Australia. The awards recognise excellence in the health and medical research sector and the exceptional contributions of Australian researchers to their fields of research.

“These awards are an opportunity to celebrate the extraordinary quality of health and medical research in Australia today,” says NHMRC CEO, Professor Anne Kelso AO.

Header image L-R: NHMRC Council Chair, Professor Bruce Robinson AM; Dr Steven Wise, HRI Applied Materials Group Leader; NHMRC CEO, Professor Anne Kelso AO.

Image credit: Irene Dowdy 


Related news

Nano ‘junk’ could save lives

We have developed a simple, cheap and efficient way to collect nanoparticles that can be used in the treatment of cancer, cardiovascular disease and Alzheimer’s.

Read more

Professor Annemarie Hennessy AM named Distinguished Professor

Congratulations to Professor Annemarie Hennessy AM, recently named Distinguished Professor by Western Sydney University.

Read more

HRI scientists pursue implant ‘Holy Grail’

In a world-first discovery, scientists at the Heart Research Institute have developed a high-tech coating that regulates the body’s often severe immune response to synthetic implants. This brings us one step closer to an exciting future where the human body does not reject lifesaving coronary bypass implants. 

Read more